Activation of inducible nitric oxide synthase by Kagamjuaguiem in peritoneal macrophages in mice

Indian Journal of Medical Research

Volumn 125, Issue 6, 2007, Pages 740-746

  An, Hyo Jin ^a,b   Um, Jae Young ^a   Na, Ho Jeong ^c   Jeong, Sejin ^b   Kim, Hyung Min ^a   Hong, Seung Heon ^b  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Kagamjuaguiem; Macrophages; Nitric oxide; Tumour necrosis Factor

Indexed keywords

ANEMARRHENA EXTRACT; ANTINEOPLASTIC AGENT; ARMENIACA AMARUM EXTRACT; ASPARAGUS EXTRACT; ASTERIS EXTRACT; CITRUS RETICULATA EXTRACT; DIOSCOREA EXTRACT; EPHEDRA EXTRACT; FARFARA EXTRACT; FRITILLARIA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KAGAMJUAGUIEM; LYCIUM EXTRACT; MORI RADICIS EXTRACT; NITRIC OXIDE; OPHIOPOGON ROOT; PERILLA EXTRACT; PEUCEDANI EXTRACT; PINELLIA EXTRACT; PLANT EXTRACT; PLATYCODON EXTRACT; PONCIRUS SEU AURANTII EXTRACT; PORIA EXTRACT; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT GAMMA INTERFERON; REHMANNIA EXTRACT; SCHISANDRA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANEMARRHENA; ANIMAL CELL; ANIMAL CELL CULTURE; ANTINEOPLASTIC ACTIVITY; ARMENIACA AMARUM; ARTICLE; ASPARAGUS; ASTERIS; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FARFARA; FRITILLARIA; LYCIUM; MANDARIN; MEDICINAL PLANT; MORI RADICIS; MOUSE; NONHUMAN; PERILLA; PERITONEUM MACROPHAGE; PEUCEDANI; PLATYCODON; PONCIRI SEU AURANTII; PORIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SCHISANDRACEAE; WESTERN BLOTTING; YAM;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERFERON TYPE II; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; PLANT PREPARATIONS; PROTEIN ISOFORMS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548428396     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jang GB. Kungakgeonseo. DaeGu (Republic of Korea). Dongyang total communication education publishing company; 1982.
2. Choi JK, Youl YD. Bibliographical studies on the effect of "Joa-gui Em". The Collection of Papers in Daejeon University Oriental Medicine Research Institute 2005; 14: 101-12.
3. Nathan CF, Hibbs JB, Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
4. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 2001; 167: 893-901.
5. Hibbs JB, Jr., Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987; 138: 550-65.
6. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-64.
7. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-8.
8. Kadkhodaee M, Qasemi A. Inbition of inducible nitric oxide synthase reduces lipopolysaccharide-induced renal injury in the rat. Clin Exp Pharmacol Physiol 2004; 31: 842-6.
9. Koo HN, Hong SH, Seo.HG, Yoo TS, Lee KN, Kim NS, et al. Inulin stimulates NO synthesis via activation of PKC-alpha and protein tyrosine kinase, resulting in the activation of NF-kappaB by IFN-gamma-primed RAW 264.7 cells. J Nutr Biochem 2003; 14:598-605.
10. Griscavage JM, Wilk S, Ignarro LJ. Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene. Biochem Biophys Res Commun 1995; 215: 721-9.
11. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491-503.
12. Chung HS, An HJ, Jeong HJ, Won JH, Hong SH, Kim HM. Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. J Pharm Pharmacol 2004; 56: 129-34.
13. Hanada, T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002; 13: 413-21.
14. Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park HJ, et al. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett 2004; 571: 50-4.
15. Kim SJ, Jeong HJ, Moon PD, Lee KM, Lee HB, Jung HJ, et al. Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-kappa B activation in peritoneal macrophages. Biol Pharm Bull 2005; 28: 233-7.
16. Jeong HJ, Chung HS, Hong SH, Na HJ, Koo HY, Seo SB, et al. CancerB increases production of nitric oxide and tumor necrosis factor-alpha in peritoneal macrophages. Clin Chim Acta 2002; 322: 149-56.
17. Hrabak A, Bajor T, Csuka I. The effect of various inflammatory agents on the alternative metabolic pathways of arginine in mouse and rat macrophages. Inflamm Res 2006; 55: 23-31.
18. Shin HY, Jeong HJ, Na HJ, Kim HJ, Moon G, Shin TY, et al. The imunosuppressive effect of Gamisanghyulyunbueum through inhibition of mitogen-activated protein kinase and nuclear factor activation in MOLT-4 cells. Biol Pharm Bull 2005; 28: 1177-82.
19. Lorsbach RB, Murphy WJ, Lowenstein CJ, Snyder SH, Russell SW. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem 1993; 268: 1908-13.
20. Frankova D, Zidek Z. IFN-gamma-induced TNF-alpha is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN-gamma. Eur J Immunol 1998; 28: 838-43.
21. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543-55.
22. Li LM, Kilbourn RG, Adams J, Fidler IJ. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 1991; 51: 2531-5.
23. Klimp AH, de Vries EG, Scherphof GL, Daemen T. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 2002; 44: 143-61.
24. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003; 384: 1343-64.
25. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141-79.
26. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994; 180: 977-84.
27. Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem 1997; 272: 1226-30.
28. Kim YM, Paik SG. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells. Biochem Biophys Res Commun 2005; 326: 410-6.
29. Kim SW, Oh HM, Kim BS, Chung HT, Han WC, Kim EC, et al. Soluble factor from tumor cells induces heme oxygenase-1 by a nitric oxide-independent mechanism in murine peritoneal macrophages. Exp Mol Med 2003; 35: 53-9.
30. Windbichler GH, Hausmaninger H, Stummvoll W, Graf AH, Kainz C, Lahodny J. et al. Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. Br J Cancer 2000; 82: 1138-44.
31. Schinkel C, Licht K, Zedler S, Schinkel S, Fuchs D, Faist E. Perioperative treatment with human recombinant interferon-gamma: a randomized double-blind clinical trial. Shock 2001; 16: 329-33.